These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23467033)

  • 1. Predicting coronary no-reflow in patients with acute myocardial infarction.
    Jaffe R
    Cardiology; 2013; 124(3):151-2. PubMed ID: 23467033
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting the no-reflow phenomenon following successful percutaneous coronary intervention.
    Galiuto L; Paraggio L; Liuzzo G; de Caterina AR; Crea F
    Biomark Med; 2010 Jun; 4(3):403-20. PubMed ID: 20550474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic significance of admission N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction].
    Wang ZY; Liu N; Lei LC; Ren LH; Ye HM; Peng JJ
    Zhonghua Yi Xue Za Zhi; 2012 Dec; 92(48):3403-6. PubMed ID: 23327699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
    Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of no-reflow phenomena after primary percutaneous coronary intervention: a time-dependent analysis of mortality.
    Choo EH; Kim PJ; Chang K; Ahn Y; Jeon DS; Lee JM; Kim DB; Her SH; Park CS; Kim HY; Yoo KD; Jeong MH; Seung KB
    Coron Artery Dis; 2014 Aug; 25(5):392-8. PubMed ID: 24625688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of initial and residual thrombus burden on the no-reflow phenomenon in patients with ST-segment elevation myocardial infarction.
    Ahn SG; Choi HH; Lee JH; Lee JW; Youn YJ; Yoo SY; Cho BR; Lee SH; Yoon J
    Coron Artery Dis; 2015 May; 26(3):245-53. PubMed ID: 25503419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Kurtul A; Murat SN; Yarlioglues M; Duran M; Celik IE; Kilic A
    Angiology; 2015 Aug; 66(7):644-51. PubMed ID: 25124682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
    Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clopidogrel resistance on ST-segment resolution and no-reflow in acute myocardial infarction with ST-elevation patients treated with a primary percutaneous coronary intervention.
    Bozbeyoglu E; Satilmis S; Aksu H; Yildirimturk O; Nurkalem Z
    Coron Artery Dis; 2012 Dec; 23(8):523-7. PubMed ID: 23011413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal extent of lipid pool assessed by optical coherence tomography predicts microvascular no-reflow after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Ikenaga H; Ishihara M; Inoue I; Kawagoe T; Shimatani Y; Miura F; Nakama Y; Dai K; Ohtani T; Ohi K; Miki T; Nakamura M; Kishimoto S; Sumimoto Y; Kihara Y
    J Cardiol; 2013 Aug; 62(2):71-6. PubMed ID: 23680004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic pretreatment of angiotensin-converting receptor blocker on no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Hu T; Wang HC; Wang RT; Lv AL; Luan RH; Li CX; Cheng HX; Xia CH; Tao L
    Cardiovasc Ther; 2013 Jun; 31(3):e7-e11. PubMed ID: 22953997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
    Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SYNTAX score is a predictor of angiographic no-reflow in patients with ST-elevation myocardial infarction treated with a primary percutaneous coronary intervention.
    Şahin DY; Gür M; Elbasan Z; Kuloğlu O; Şeker T; Kivrak A; Tanboğa İH; Gözübüyük G; Kirim S; Çayli M
    Coron Artery Dis; 2013 Mar; 24(2):148-53. PubMed ID: 23363986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of no-reflow after percutaneous coronary intervention for culprit lesion with plaque rupture in infarct-related artery in patients with acute myocardial infarction.
    Hong YJ; Jeong MH; Choi YH; Ko JS; Lee MG; Kang WY; Lee SE; Kim SH; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    J Cardiol; 2009 Aug; 54(1):36-44. PubMed ID: 19632518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of NT-proBNP on admission for early risk stratification of patients undergoing primary percutaneous coronary intervention.
    Ayhan E; Isık T; Uyarel H; Ergelen M; Cicek G; Ozyurtlu F; Ghannadian B; Tanboga IH
    Kardiol Pol; 2013; 71(2):165-75. PubMed ID: 23575711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of no-reflow in culprit lesion versus culprit vessel PCI in acute STEMI.
    Arslan U; Yaman M; Kocaoğlu İ; Turan OE; Yücel H; Aksakal A; Günaydin İA; Hakan Ateş A
    Coron Artery Dis; 2015 Sep; 26(6):510-5. PubMed ID: 26086864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Ocek AH; Murat SN; Yarlioglues M; Demircelik MB; Duran M; Ergun G; Cay S
    Angiology; 2015 Mar; 66(3):278-85. PubMed ID: 24650948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.